MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202641106219 A) filed by Saveetha Institute Of Medical And Technical Sciences on September 03, 2026, for Smart Drug Delivery System With Controllerd Release For Targeted Theraph.
Inventors include P. Chennake Shava; Dr T Sathish; Rithika Srinivasan; and Dr Ramya Mohan.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present invention relates to a smart drug delivery system designed to provide controlled and targeted release of therapeutic agents to specific biological sites. The system integrates sensing, control, and delivery mechanisms to ensure precise dosage administration based on real-time physiological conditions. Unlike conventional drug delivery methods that rely on fixed dosing schedules, the proposed system dynamically regulates drug release in response to predefined biological parameters such as pH, temperature, or biomarker concentration. The system comprises a drug reservoir, a micro-controlled release unit, biosensors, and a delivery actuator that collectively enable accurate and sustained therapy. The intelligent control unit processes sensor data and triggers the release mechanism only when therapeutic conditions are met, thereby minimizing drug wastage and reducing systemic side effects. The invention supports multiple modes of delivery including oral, transdermal, and implantable configurations, making it adaptable to various clinical applications. By ensuring localized and time-specific drug administration, the system enhances therapeutic efficiency while improving patient compliance. The controlled release mechanism also allows for adjustable dosage profiles, making it suitable for chronic disease management and personalized medicine. The smart drug delivery system thus offers a reliable, automated, and patient-centric solution that overcomes the limitations of traditional drug administration techniques
Disclaimer: Curated by HT Syndication.
